NEUROPACE, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
NEUROPACE, INC. (NPCE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $917.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-11
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $464.00K, a 9.95% increase year-over-year.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $453.00K, a 9.69% increase year-over-year.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $442.00K, a 9.68% increase year-over-year.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $433.00K, a 9.62% increase year-over-year.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $1.71M, a 9.48% increase from fiscal 2024.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $1.56M, a 9.00% increase from fiscal 2023.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2023 was $1.43M, a 47.32% decline from fiscal 2022.
- NEUROPACE, INC. operating lease, right-of-use asset, amortization expense for fiscal 2022 was $2.72M.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $464.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $917.00K 10-Q · filed 2026-08-11 | $1.36M derived: sum of 3 quarters · filed 2026-08-11 | $1.79M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $453.00K 10-Q · filed 2026-05-12 | $895.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.33M derived: sum of 3 quarters · filed 2026-05-12 | $1.75M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $875.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.30M derived: sum of 3 quarters · filed 2026-08-11 | $1.71M 10-K · filed 2026-03-03 |
| 2025-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $855.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.27M 10-Q · filed 2025-11-04 | $1.67M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $422.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $835.00K 10-Q · filed 2026-08-11 | $1.24M derived: sum of 3 quarters · filed 2026-08-11 | $1.63M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $413.00K 10-Q · filed 2026-05-12 | $816.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.21M derived: sum of 3 quarters · filed 2026-05-12 | $1.60M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $403.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $798.00K derived: sum of 2 quarters · filed 2026-03-03 | $1.18M derived: sum of 3 quarters · filed 2026-03-03 | $1.56M 10-K · filed 2026-03-03 |
| 2024-09-30 | $395.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $781.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.16M 10-Q · filed 2025-11-04 | $1.53M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $764.00K 10-Q · filed 2025-08-12 | $1.13M derived: sum of 3 quarters · filed 2025-08-12 | $1.50M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $378.00K 10-Q · filed 2025-05-13 | $747.00K derived: sum of 2 quarters · filed 2025-05-13 | $1.11M derived: sum of 3 quarters · filed 2025-05-13 | $1.46M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $731.00K derived: sum of 2 quarters · filed 2025-03-04 | $1.09M derived: sum of 3 quarters · filed 2025-03-04 | $1.43M 10-K · filed 2025-03-04 |
| 2023-09-30 | $362.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $717.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.06M 10-Q · filed 2024-11-12 | $1.76M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $355.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $702.00K 10-Q · filed 2024-08-13 | $1.40M derived: sum of 3 quarters · filed 2024-08-13 | $2.08M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $347.00K 10-Q · filed 2024-05-08 | $1.04M derived: sum of 2 quarters · filed 2024-05-08 | $1.72M derived: sum of 3 quarters · filed 2024-05-08 | $2.40M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.38M derived: sum of 2 quarters · filed 2024-03-05 | $2.05M derived: sum of 3 quarters · filed 2024-03-05 | $2.72M 10-K · filed 2024-03-05 |
| 2022-09-30 | $679.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $1.35M derived: sum of 2 quarters · filed 2023-11-06 | $2.02M 10-Q · filed 2023-11-06 | $2.02M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $1.34M 10-Q · filed 2023-08-08 | $1.34M derived: sum of 3 quarters · filed 2023-08-08 | $1.34M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $672.00K 10-Q · filed 2023-05-04 | $672.00K derived: sum of 2 quarters · filed 2023-05-04 | $672.00K derived: sum of 3 quarters · filed 2023-05-04 | $672.00K derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 derived: sum of 3 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |